151 related articles for article (PubMed ID: 10898572)
1. Synthesis, conjugation, and radiolabeling of a novel bifunctional chelating agent for (225)Ac radioimmunotherapy applications.
Chappell LL; Deal KA; Dadachova E; Brechbiel MW
Bioconjug Chem; 2000; 11(4):510-9. PubMed ID: 10898572
[TBL] [Abstract][Full Text] [Related]
2. Improved in vivo stability of actinium-225 macrocyclic complexes.
Deal KA; Davis IA; Mirzadeh S; Kennel SJ; Brechbiel MW
J Med Chem; 1999 Jul; 42(15):2988-92. PubMed ID: 10425108
[TBL] [Abstract][Full Text] [Related]
3. Actinium-225 conjugates of MAb CC49 and humanized delta CH2CC49.
Kennel SJ; Brechbiel MW; Milenic DE; Schlom J; Mirzadeh S
Cancer Biother Radiopharm; 2002 Apr; 17(2):219-31. PubMed ID: 12030116
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumors.
Kennel SJ; Chappell LL; Dadachova K; Brechbiel MW; Lankford TK; Davis IA; Stabin M; Mirzadeh S
Cancer Biother Radiopharm; 2000 Jun; 15(3):235-44. PubMed ID: 10941530
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy.
Kang CS; Sun X; Jia F; Song HA; Chen Y; Lewis M; Chong HS
Bioconjug Chem; 2012 Sep; 23(9):1775-82. PubMed ID: 22881720
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides.
Garmestani K; Yao Z; Zhang M; Wong K; Park CW; Pastan I; Carrasquillo JA; Brechbiel MW
Nucl Med Biol; 2001 May; 28(4):409-18. PubMed ID: 11395314
[TBL] [Abstract][Full Text] [Related]
7. Influence of the linker on the biodistribution and catabolism of actinium-225 self-immolative tumor-targeted isotope generators.
Antczak C; Jaggi JS; LeFave CV; Curcio MJ; McDevitt MR; Scheinberg DA
Bioconjug Chem; 2006; 17(6):1551-60. PubMed ID: 17105236
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb.
Chappell LL; Dadachova E; Milenic DE; Garmestani K; Wu C; Brechbiel MW
Nucl Med Biol; 2000 Jan; 27(1):93-100. PubMed ID: 10755652
[TBL] [Abstract][Full Text] [Related]
9.
Pfannkuchen N; Bausbacher N; Pektor S; Miederer M; Rosch F
Curr Radiopharm; 2018; 11(3):223-230. PubMed ID: 29866026
[TBL] [Abstract][Full Text] [Related]
10. H
Kadassery KJ; King AP; Fayn S; Baidoo KE; MacMillan SN; Escorcia FE; Wilson JJ
Bioconjug Chem; 2022 Jun; 33(6):1222-1231. PubMed ID: 35670495
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion.
Wu Y; Zhu H; Zhang B; Liu F; Chen J; Wang Y; Wang Y; Zhang Z; Wu L; Si L; Xu H; Yao T; Xiao S; Xia Q; Zhang L; Yang Z; Zhou D
Bioconjug Chem; 2016 Oct; 27(10):2460-2468. PubMed ID: 27617674
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of 225Ac radioimmunopharmaceuticals.
McDevitt MR; Ma D; Simon J; Frank RK; Scheinberg DA
Appl Radiat Isot; 2002 Dec; 57(6):841-7. PubMed ID: 12406626
[TBL] [Abstract][Full Text] [Related]
13. Efficient 1-step radiolabeling of monoclonal antibodies to high specific activity with 225Ac for α-particle radioimmunotherapy of cancer.
Maguire WF; McDevitt MR; Smith-Jones PM; Scheinberg DA
J Nucl Med; 2014 Sep; 55(9):1492-8. PubMed ID: 24982438
[TBL] [Abstract][Full Text] [Related]
14. Convenient Synthesis and Evaluation of Heptadentate Bifunctional Ligand for Radioimmunotherapy Applications.
Chong HS; Sun X; Dong P; Kang CS
European J Org Chem; 2011 Nov; 2011(33):6641-6648. PubMed ID: 23794941
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins.
Chappell LL; Ma D; Milenic DE; Garmestani K; Venditto V; Beitzel MP; Brechbiel MW
Nucl Med Biol; 2003 Aug; 30(6):581-95. PubMed ID: 12900284
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents.
Safavy A; Buchsbaum DJ; Khazaeli MB
Bioconjug Chem; 1993; 4(3):194-8. PubMed ID: 8324008
[TBL] [Abstract][Full Text] [Related]
17. Encapsulation of α-Particle-Emitting 225Ac3+ Ions Within Carbon Nanotubes.
Matson ML; Villa CH; Ananta JS; Law JJ; Scheinberg DA; Wilson LJ
J Nucl Med; 2015 Jun; 56(6):897-900. PubMed ID: 25931476
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and application of a novel cysteine-based DTPA-NCS for targeted radioimmunotherapy.
Lee SY; Hong YD; Kim HS; Choi SJ
Nucl Med Biol; 2013 Apr; 40(3):424-9. PubMed ID: 23357082
[TBL] [Abstract][Full Text] [Related]
19. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.
Kozak RW; Raubitschek A; Mirzadeh S; Brechbiel MW; Junghans RP; Gansow OA; Waldmann TA
Cancer Res; 1989 May; 49(10):2639-44. PubMed ID: 2785435
[TBL] [Abstract][Full Text] [Related]
20. Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA).
Chappell LL; Rogers BE; Khazaeli MB; Mayo MS; Buchsbaum DJ; Brechbiel MW
Bioorg Med Chem; 1999 Nov; 7(11):2313-20. PubMed ID: 10632041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
